Your session is about to expire
← Back to Search
Telemedicine Visit for Kidney Failure
N/A
Waitlist Available
Led By Aditya Mattoo, MD
Research Sponsored by NYU Langone Health
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 4 months
Awards & highlights
Study Summary
The purpose of this study is to determine whether a telemedicine follow-up visit at the NYU Langone Transplant Institute is a feasible and acceptable alternative to a traditional in-center follow-up visit.
Eligible Conditions
- Kidney Failure
- Chronic Kidney Disease
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 4 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~4 months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Cost
Missed visits
Waiting time
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Telemedicine VisitExperimental Treatment1 Intervention
Group II: Usual Care VisitActive Control1 Intervention
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Telemedicine Visit
2017
N/A
~20
Find a Location
Who is running the clinical trial?
NYU Langone HealthLead Sponsor
1,369 Previous Clinical Trials
840,494 Total Patients Enrolled
Aditya Mattoo, MDPrincipal InvestigatorNYU Langone Health
Nicole Ali, MDPrincipal InvestigatorNYU Langone Health
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Share this study with friends
Copy Link
Messenger